Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services Research

Postpregnancy BMI in the Progression From Hypertensive Disorders of Pregnancy to Type 2 Diabetes

  1. Simon Timpka1,2,3⇑,
  2. Jennifer J. Stuart1,2,4,
  3. Lauren J. Tanz1,4,
  4. Frank B. Hu2,5,6,
  5. Paul W. Franks3,5 and
  6. Janet W. Rich-Edwards1,2,4
  1. 1Connors Center for Women’s Health and Gender Biology, Division of Women’s Health, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
  2. 2Harvard Medical School, Boston, MA
  3. 3Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
  4. 4Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  5. 5Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
  6. 6Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
  1. Corresponding author: Simon Timpka, simon.timpka{at}med.lu.se
Diabetes Care 2019 Jan; 42(1): 44-49. https://doi.org/10.2337/dc18-1532
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    The joint effect of BMI after pregnancy and history of HDP on the risk of type 2 diabetes in women without a history of gestational diabetes mellitus by BMI, presented as HRs partitioned into the relative excess risks due to BMI, HDP, and their interaction (RERI). For each category of BMI, we show the relative excess risk due to each risk factor (BMI or HDP) and their additive interaction (RERI); the latter is supported if RERI >0. For example, in women with BMI ≥35.0 kg/m2, RERI is calculated as follows: RERIBMI ≥35.0 = HRBMI ≥35.0, HDP − HRBMI ≥18.5–24.9, HDP − HRBMI ≥35.0, No HDP + 1. All HRs are adjusted for age, race/ethnicity, parity, diet, physical activity, BMI at age 18 years, menopausal status, alcohol, smoking, and parental history of diabetes.

Tables

  • Figures
  • Table 1

    Descriptive characteristics of the study sample at study entry by history of HDP

    VariableNo HDP (n = 49,596)HDP (n = 6,563)
    Age, years, mean (SD)46.3 (1.1)46.3 (1.2)
    History of preeclampsia in any pregnancy*n/a4,325 (65.9)
    History of gestational hypertension in any pregnancy*n/a3,736 (56.9)
    BMI at age 18 years, kg/m2, mean (SD)†20.9 (2.8)21.7 (3.3)
    Parental history of diabetes 14,709 (29.7)2,112 (32.2)
    Current BMI, kg/m2, mean (SD)25.9 (5.3)28.7 (6.4)
    Current BMI, kg/m2
     18.5–24.926,577 (53.6)2,261 (34.5)
     25.0–29.913,688 (27.6)1,949 (29.7)
     30.0–34.95,868 (11.8)1,224 (18.7)
     35.0–50.03,463 (7.0)1,129 (17.2)
    Physical activity, METs/week
     Fourth quartile (high activity)12,273 (24.7)1,455 (22.2)
     Third quartile12,411 (25.0)1,547 (23.6)
     Second quartile12,533 (25.3)1,713 (26.1)
     First quartile (low activity)12,379 (25.0)1,848 (28.2)
    DASH diet score
     Fourth quartile (high adherence)10,917 (22.0)1,316 (20.1)
     Third quartile13,380 (27.0)1,786 (27.2)
     Second quartile12,439 (25.1)1,693 (25.8)
     First quartile (low adherence)12,860 (25.9)1,768 (26.9)
    Race/ethnicity
     White/Caucasian46,232 (93.2)6,157 (93.8)
     African American547 (1.1)83 (1.3)
     Latina620 (1.3)84 (1.3)
     Asian656 (1.3)52 (0.8)
     Other806 (1.6)93 (1.4)
     Missing735 (1.5)94 (1.4)
    Alcohol intake
     No intake19,180 (38.7)2,832 (43.2)
     1–15 g/day27,078 (54.6)3,347 (51.0)
     >15 g/day3,338 (6.7)384 (5.9)
    Smoking status
     Never32,832 (66.2)4,308 (65.6)
     Past12,627 (25.5)1,716 (26.1)
     Current4,137 (8.3)539 (8.2)
    Parity
     1 birth8,250 (16.6)1,223 (18.6)
     2 births24,293 (49.0)3,137 (47.8)
     3 or more births17,053 (34.4)2,203 (33.6)
    Menopausal status
     Premenopause41,853 (84.4)5,354 (81.6)
     Postmenopause6,340 (12.8)995 (15.2)
     Unknown1,403 (2.8)214 (3.3)
    • Data are n (%) unless otherwise indicated. n/a, not applicable.

    • ↵*Categories not mutually exclusive.

    • ↵†Missing = 445 (0.8%).

  • Table 2

    Incidence rates and HRs for type 2 diabetes according to BMI by history of HDP in parous middle-aged women without history of gestational diabetes mellitus

    Incidence rates
    Normal weight (18.5–24.9 kg/m2)Overweight (25.0–29.9 kg/m2)Obesity class I (30.0–34.9 kg/m2)Obesity class II–III (≥35.0 kg/m2)Total
    Crude incidence
     No HDP
      Events/person-years*60/193,169221/113,891313/50,566443/29,3061,037/386,932
      Incidence per 1,000 person-years0.311.96.215.12.7
     History of HDP
      Events/person-years*10/15,57340/15,36096/9,934158/8,534304/49,401
      Incidence per 1,000 person-years0.642.69.718.56.2
    HR (95% CI)
    Normal weight (18.5–24.9 kg/m2)Overweight (25.0–29.9 kg/m2)Obesity class I (30.0–34.9 kg/m2)Obesity class II–III (≥35.0 kg/m2)Ptrend†
    Basic Cox regression model
     No HDP‡1.00 (Ref)6.18 (4.65, 8.23)19.60 (14.85, 25.87)46.94 (35.79, 61.56)<0.001
     History of HDP‡1.00 (Ref)§3.96 (1.98, 7.92)14.73 (7.67, 28.28)29.60 (15.60, 56.17)<0.001
    Main Cox regression model
     No HDP‡1.00 (Ref)5.89 (4.42, 7.85)18.20 (13.72, 24.13)44.6 (33.56, 59.25)<0.001
     History of HDP‡1.00 (Ref)§3.83 (1.91, 7.67)14.44 (7.50, 27.80)28.78 (15.06, 54.98)<0.001
    • Ref, reference group. Women categorized as underweight (BMI <18.5 kg/m2) or with BMI >50 kg/m2 are excluded. Basic models include adjustment for age, race/ethnicity (white, Latina, African American, Asian, or other), and parity (1, 2, or ≥3 births). Main models additionally include DASH diet score (quartiles), physical activity (quartiles), BMI at age 18 years, smoking (nonsmoker, current smoker, or former smoker), alcohol intake (none, 1–15 g/day, or >15 g/day), menopausal status (premenopausal, postmenopausal, or unknown), parental history of diabetes (yes/no), and interaction terms between HDP and BMI categories.

    • ↵*Rounded to year.

    • ↵†Continuous BMI included in the models instead of categorical BMI.

    • ↵‡Separate Cox proportional hazards models by HDP history.

    • ↵§The same model as for “no HDP” except that women with prior HDP and BMI 18.5–24.9 kg/m2 constitute the reference group.

  • Table 3

    Statistics for additive interaction between postpregnancy BMI and history of HDP in multivariable-adjusted models of incident type 2 diabetes in parous women without history of gestational diabetes mellitus

    Additive interaction statisticBMI category (kg/m2)
    Normal weight (18.5–24.9)Overweight (25.0–29.9)Obesity class I (30.0–34.9)Obesity class II–III (≥35.0)
    RERI (95% CI), null = 0Reference*0.98 (−1.92, 3.87)10.69 (3.67, 17.70)14.02 (2.83, 25.22)
    Attributable proportion (95% CI), null = 0†Reference*0.12 (−0.22, 0.46)0.36 (0.13, 0.59)0.24 (0.05, 0.42)
    Synergy index (95% CI), null = 1Reference*1.16 (0.72, 1.60)1.59 (1.34, 1.83)1.31 (1.12, 1.51)
    • ↵*The reference group is women with BMI 18.5–24.9 kg/m2 and no history of HDP.

    • ↵†The proportion of risk that is attributable to the additive interaction between postpregnancy BMI and history of HDP.

PreviousNext
Back to top
Diabetes Care: 42 (1)

In this Issue

January 2019, 42(1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Postpregnancy BMI in the Progression From Hypertensive Disorders of Pregnancy to Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Postpregnancy BMI in the Progression From Hypertensive Disorders of Pregnancy to Type 2 Diabetes
Simon Timpka, Jennifer J. Stuart, Lauren J. Tanz, Frank B. Hu, Paul W. Franks, Janet W. Rich-Edwards
Diabetes Care Jan 2019, 42 (1) 44-49; DOI: 10.2337/dc18-1532

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Postpregnancy BMI in the Progression From Hypertensive Disorders of Pregnancy to Type 2 Diabetes
Simon Timpka, Jennifer J. Stuart, Lauren J. Tanz, Frank B. Hu, Paul W. Franks, Janet W. Rich-Edwards
Diabetes Care Jan 2019, 42 (1) 44-49; DOI: 10.2337/dc18-1532
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Conclusions
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes
  • Quantifying Variation in Treatment Utilization for Type 2 Diabetes Across Five Major University of California Health Systems
  • Trends in Total and Out-of-pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018
Show more Epidemiology/Health Services Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.